BCM
AUPH icon

Burrage Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Burrage Capital Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-336,384
Closed -$4.65M – 28
2020
Q4 		$4.65M Sell
336,384
-25,999
-7% -$378K 3.55% 13
2020
Q3 		$5.34M Buy
362,383
+105,945
+41% +$1.53M 4.21% 10
2020
Q2 		$4.17M Buy
256,438
+60,000
+31% +$961K 2.92% 18
2020
Q1 		$2.9M Buy
196,438
+69,905
+55% +$1.23M 2.86% 18
2019
Q4 		$2.56M Buy
+126,533
New +$1.17M 1.72% 18

Other funds holding AUPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Burrage Capital Management's AUPH Position: Q1 2021 in Review

Burrage Capital Management sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2021, closing a stake of 336,384 shares — an estimated $4.65M sold.

Burrage Capital Management first reported a position in AUPH in Q4 2019 and held it in 5 quarters. The position peaked at $5.34M in Q3 2020. 170 funds tracked by Wall St. Rank hold AUPH as of Q1 2021.

  • Burrage Capital Management reported no remaining Aurinia Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Burrage Capital Management sold 336,384 Aurinia Pharmaceuticals shares in Q1 2021, an estimated $4.65M.
  • Burrage Capital Management first reported a position in Aurinia Pharmaceuticals in Q4 2019 and held it in 5 quarters.
  • Burrage Capital Management's Aurinia Pharmaceuticals position peaked at $5.34M in Q3 2020.
  • 170 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2021.

Based on Burrage Capital Management's 13F filing for Q1 2021, filed 17 May 2021.